Hjem › Diffus sclerodermi › Kansas › Kansas City
Diffus sclerodermi kliniske forsøg i Kansas City, KS
4 studier for Diffus sclerodermi søger deltagere på steder i og omkring Kansas City (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
RekruttererFase 2
- EncompaSSc site in Kansas City, KS, Kansas City
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RekruttererFase 1
- University of Kansas Medical Center, Kansas City
Platform Clinical Study for Conquering Scleroderma
RekruttererFase 2
- University of Kansas School of Medicine, Kansas City
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RekruttererFase 2/3
- University of Kansas Medical Center, Kansas City
Diffus sclerodermi forsøg i andre byer
- New York City, NY8 studier
- Ann Arbor, MI7 studier
- Chicago, IL7 studier
- Durham, NC6 studier
- Los Angeles, CA6 studier
- Houston, TX5 studier
- Boston, MA5 studier
- Baltimore, MD5 studier
- Pittsburgh, PA4 studier
- New Orleans, LA4 studier
- Philadelphia, PA4 studier
- Charlotte, NC3 studier
Andre studier i Kansas City
- Kardiovaskulær sygdom14 studier
- Interstitielle lungesygdomme13 studier
- Hjertesvigt13 studier
- Overvægt13 studier
- Cystisk fibrose13 studier
- Blærecancer12 studier
- Prostatakræft12 studier
- Brystkræft12 studier
- Ikke-småcellet lungecancer11 studier
- Akut myeloid leukæmi11 studier
- Lungecancer11 studier
- KOL9 studier
Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.